These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 21289068)

  • 1. MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer.
    Png KJ; Yoshida M; Zhang XH; Shu W; Lee H; Rimner A; Chan TA; Comen E; Andrade VP; Kim SW; King TA; Hudis CA; Norton L; Hicks J; Massagué J; Tavazoie SF
    Genes Dev; 2011 Feb; 25(3):226-31. PubMed ID: 21289068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
    Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
    Sengupta D; Deb M; Rath SK; Kar S; Parbin S; Pradhan N; Patra SK
    Exp Cell Res; 2016 Aug; 346(2):176-87. PubMed ID: 27475839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter.
    Poli E; Zhang J; Nwachukwu C; Zheng Y; Adedokun B; Olopade OI; Han YJ
    PLoS One; 2015; 10(11):e0142224. PubMed ID: 26539832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic silencing of Kruppel like factor-3 increases expression of pro-metastatic miR-182.
    Sachdeva M; Dodd RD; Huang Z; Grenier C; Ma Y; Lev DC; Cardona DM; Murphy SK; Kirsch DG
    Cancer Lett; 2015 Dec; 369(1):202-11. PubMed ID: 26314219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous human microRNAs that suppress breast cancer metastasis.
    Tavazoie SF; Alarcón C; Oskarsson T; Padua D; Wang Q; Bos PD; Gerald WL; Massagué J
    Nature; 2008 Jan; 451(7175):147-52. PubMed ID: 18185580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A microRNA DNA methylation signature for human cancer metastasis.
    Lujambio A; Calin GA; Villanueva A; Ropero S; Sánchez-Céspedes M; Blanco D; Montuenga LM; Rossi S; Nicoloso MS; Faller WJ; Gallagher WM; Eccles SA; Croce CM; Esteller M
    Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13556-61. PubMed ID: 18768788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation of microRNA expression in colorectal cancer.
    Bandres E; Agirre X; Bitarte N; Ramirez N; Zarate R; Roman-Gomez J; Prosper F; Garcia-Foncillas J
    Int J Cancer; 2009 Dec; 125(11):2737-43. PubMed ID: 19521961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer.
    Zhang L; Yan DL; Yang F; Wang DD; Chen X; Wu JZ; Tang JH; Xia WJ
    Oncotarget; 2017 Jul; 8(28):45496-45505. PubMed ID: 28525377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells.
    de Souza Rocha Simonini P; Breiling A; Gupta N; Malekpour M; Youns M; Omranipour R; Malekpour F; Volinia S; Croce CM; Najmabadi H; Diederichs S; Sahin O; Mayer D; Lyko F; Hoheisel JD; Riazalhosseini Y
    Cancer Res; 2010 Nov; 70(22):9175-84. PubMed ID: 20978187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
    Wu H; Li J; Guo E; Luo S; Wang G
    Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays.
    Rodenhiser DI; Andrews J; Kennette W; Sadikovic B; Mendlowitz A; Tuck AB; Chambers AF
    Breast Cancer Res; 2008; 10(4):R62. PubMed ID: 18638373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11.
    Cai WL; Huang WD; Li B; Chen TR; Li ZX; Zhao CL; Li HY; Wu YM; Yan WJ; Xiao JR
    Mol Cancer; 2018 Jan; 17(1):9. PubMed ID: 29343249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homeobox protein MSX1 inhibits the growth and metastasis of breast cancer cells and is frequently silenced by promoter methylation.
    Yue Y; Yuan Y; Li L; Fan J; Li C; Peng W; Ren G
    Int J Mol Med; 2018 May; 41(5):2986-2996. PubMed ID: 29436596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of miR-137 by aberrant promoter hypermethylation in surgically resected lung cancer.
    Kang N; Choi SY; Kim YK; Yoo IeR; Han DH; Lee DS; Kim YS; Hong SH; Kang JH; Lee KY; Park JK; Sung SW; Park MS; Yim HW; Kim SJ; Park JY
    Lung Cancer; 2015 Aug; 89(2):99-103. PubMed ID: 26101014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer.
    Hulf T; Sibbritt T; Wiklund ED; Patterson K; Song JZ; Stirzaker C; Qu W; Nair S; Horvath LG; Armstrong NJ; Kench JG; Sutherland RL; Clark SJ
    Oncogene; 2013 Jun; 32(23):2891-9. PubMed ID: 22869146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five Hypermethylated MicroRNA Genes as Potential Markers of Ovarian Cancer.
    Braga EA; Loginov VI; Burdennyi AM; Filippova EA; Pronina IV; Kurevlev SV; Kazubskaya TP; Kushlinskii DN; Utkin DO; Ermilova VD; Kushlinskii NE
    Bull Exp Biol Med; 2018 Jan; 164(3):351-355. PubMed ID: 29313235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic relevance of miRNA-155 methylation in anaplastic glioma.
    Schliesser MG; Claus R; Hielscher T; Grimm C; Weichenhan D; Blaes J; Wiestler B; Hau P; Schramm J; Sahm F; Weiß EK; Weiler M; Baer C; Schmidt-Graf F; Schackert G; Westphal M; Hertenstein A; Roth P; Galldiks N; Hartmann C; Pietsch T; Felsberg J; Reifenberger G; Sabel MC; Winkler F; von Deimling A; Meisner C; Vajkoczy P; Platten M; Weller M; Plass C; Wick W
    Oncotarget; 2016 Dec; 7(50):82028-82045. PubMed ID: 27880937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer.
    Cheng CW; Wang HW; Chang CW; Chu HW; Chen CY; Yu JC; Chao JI; Liu HF; Ding SL; Shen CY
    Breast Cancer Res Treat; 2012 Aug; 134(3):1081-93. PubMed ID: 22476851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.